Evidence map›Paper›PMID 31915981›Full record

ArticleJournal of neuro-oncology2020

Spatial distribution of malignant transformation in patients with low-grade glioma.

Asgeir S Jakola, David Bouget, Ingerid Reinertsen, Anne J Skjulsvik, Lisa Millgård Sagberg, Hans Kristian Bø, Sasha Gulati, Kristin Sjåvik, Ole Solheim

Abstract read
In one paragraph

Article in Journal of neuro-oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Asgeir S JakolaDepartment of Neuromedicine and Movement Science, NTNU, Trondheim, Norway. Jakola.asgeir@gu.se.ORCID http://orcid.org/0000-0002-2860-9331
David BougetDepartment of Health Research, SINTEF Digital, Trondheim, Norway.
Ingerid ReinertsenDepartment of Health Research, SINTEF Digital, Trondheim, Norway.
Anne J SkjulsvikDepartment of Pathology, St. Olavs University Hospital, Trondheim, Norway.
Lisa Millgård SagbergDepartment of Public Health and Nursing, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway.
Hans Kristian BøDepartment of Diagnostic Imaging, Nordland Hospital Trust, Bodø, Norway.
Sasha GulatiDepartment of Neuromedicine and Movement Science, NTNU, Trondheim, Norway.
Kristin SjåvikDepartment of Neurosurgery, University Hospital of North Norway, Tromsö, Norway.
Ole SolheimDepartment of Neuromedicine and Movement Science, NTNU, Trondheim, Norway.

Funding

ALF agreement ALFGBG-716671Kreftforeningen 5703787Vetenskapsrådet 2017-00944
6 · The paper itself

Abstract

backgroundMalignant transformation represents the natural evolution of diffuse low-grade gliomas (LGG). This is a catastrophic event, causing neurocognitive symptoms, intensified treatment and premature death. However, little is known concerning the spatial distribution of malignant transformation in patients with LGG. MATERIALS AND

methodsPatients histopathological diagnosed with LGG and subsequent radiological malignant transformation were identified from two different institutions. We evaluated the spatial distribution of malignant transformation with (1) visual inspection and (2) segmentations of longitudinal tumor volumes. In (1) a radiological transformation site < 2 cm from the tumor on preceding MRI was defined local transformation. In (2) overlap with pretreatment volume after importation into a common space was defined as local transformation. With a centroid model we explored if there were particular patterns of transformations within relevant subgroups.

resultsWe included 43 patients in the clinical evaluation, and 36 patients had MRIs scans available for longitudinal segmentations. Prior to malignant transformation, residual radiological tumor volumes were > 10 ml in 93% of patients. The transformation site was considered local in 91% of patients by clinical assessment. Patients treated with radiotherapy prior to transformation had somewhat lower rate of local transformations (83%). Based upon the segmentations, the transformation was local in 92%. We did not observe any particular pattern of transformations in examined molecular subgroups.

conclusionMalignant transformation occurs locally and within the T2w hyperintensities in most patients. Although LGG is an infiltrating disease, this data conceptually strengthens the role of loco-regional treatments in patients with LGG.

Indexed as

Brain NeoplasmsCell Transformation, NeoplasticFemaleFollow-Up StudiesGliomaHumansMagnetic Resonance ImagingMaleMiddle AgedNeoplasm GradingRetrospective StudiesSpatial AnalysisBrain neoplasmGliomaNeurosurgeryTransformationTreatment

Identifiers

PMID31915981
PMCPMC6971181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.